This research highlights FABP4 and FSTL1 as significant biomarkers associated with CAD and metabolic syndrome, respectively, while reaffirming the roles of adiponectin and irisin in metabolic regulation. This evidence concerns the gene FNDC5 and coronary artery disorder.